ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Generation and Long-Term Culturing of AIPCs for Islet Replacement

J. B. Pollett1, R. Bottino2, S. Bertera2, M. Trucco2, N. Thai2

1Imagine Pharma, Pittsburgh, PA, 2Allegheny Health Network, Pittsburgh, PA

Meeting: 2020 American Transplant Congress

Abstract number: 427

Keywords: Islets, Preclinical trails, Tissue-specific

Session Information

Session Name: Islet/Cell Transplantation

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:39pm-3:51pm

Location: Virtual

*Purpose: Islet transplantation is one of the most promising hopes for a cure for type 1 diabetes, although islet shortage remains a serious concern. A possible solution is to generate cells from non-islet sources (stem cells) for replacement therapy; however, current techniques are labor-intensive, require multiple steps, a myriad of factors, many weeks to obtain the desired cells, which in some cases are oncogenic, and can be very costly. We recently developed a novel cell population, AIPCs (Activated Islet Proliferating Cells), from isolated human islets using a simple culture protocol that can generate billions of insulin-producing islet cells.

*Methods: IMG-i is a reagent with a proprietary peptide that induces islet cells to mobilize and proliferate. These cells are over 65% CD133-, Ki67- and insulin-triple-positive. AIPCs are over 70% double-positive for both insulin and glucagon and can secrete both hormones when stimulated with various secretagogues. AIPCs can be cultured and expanded in vitro for long periods of time (over 200 days) and maintain their marker profile and ability to respond to physiological stimuli. When allowed to grow to confluency, AIPCs form Dithizone-positive islet-like cell clusters that respond to glucose stimulation and putatively represent de novo islets. To assess the ability of AIPCs to engraft and survive in a hyperglycemic environment, produce insulin, and avoid transformation, AIPCs (a bolus of 4 million) were transplanted under the kidney capsule of STZ-diabetic mice (n=6).

*Results: Within 14 days post-implantation, human insulin was detected in the serum; by day 56, all implanted animals were secreting human insulin until elective termination of the study after 100 days. Histological analysis of the implanted areas of the kidney capsule displayed no tumor formation and the presence of insulin-positive, islet-like formations.

*Conclusions: We present a simple culture protocol that allows the mobilization and long-term culture of insulin and glucagon-expressing islet derived cells. These cells do not display any tumorigenic effects in vivo in mice and can be transplanted without any modification or alteration. If the observed propagation rates of AIPCs are confirmed in a broader pool of islet donors, it is estimated that isolated islets from a single donor pancreas could generate 20 billion AIPCs within four weeks, which should be sufficient to treat multiple patients. AIPCs represent not only a novel cell population and tool to further study islet cell biology, but a realistic cellular approach for the treatment of diabetes.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Pollett JB, Bottino R, Bertera S, Trucco M, Thai N. Generation and Long-Term Culturing of AIPCs for Islet Replacement [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/generation-and-long-term-culturing-of-aipcs-for-islet-replacement/. Accessed May 9, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences